Know Labs Files S-1/A Amendment

TL;DR

Know Labs (KNWN) filed an S-1/A, updating its registration for securities. Watch for potential dilution or capital raise.

AI Summary

Know Labs, Inc. filed an S-1/A amendment on July 22, 2024, for its registration statement. The company, formerly known as Visualant Inc. and Starberrys Corp, is incorporated in Nevada and headquartered in Seattle, Washington. This filing relates to the registration of securities under the Securities Act of 1933.

Why It Matters

This S-1/A filing indicates Know Labs, Inc. is actively pursuing a securities offering or updating its registration, which could impact its capital structure and shareholder base.

Risk Assessment

Risk Level: medium — S-1/A filings often precede or update securities offerings, which can lead to dilution or changes in company structure, carrying inherent investment risks.

Key Numbers

• 20240722 — Filing Date (Amendment No. 3 filed on this date.)
• 333-280273 — SEC File Number (Identifies this specific registration.)
• 0930 — Fiscal Year End (Indicates the company's financial year-end.)

Key Players & Entities

• KNOW LABS, INC. (company) — Registrant
• Ronald P. Erickson (person) — Chief Executive Officer
• VISUALANT INC (company) — Former Company Name
• STARBERRYS CORP (company) — Former Company Name
• 333-280273 (dollar_amount) — SEC File Number

FAQ

Key Financial Figures

• $0.432 — stock, at an assumed offering price of $0.432 per unit, which is approximately equal
• $6.0 million — 024 for gross proceeds of approximately $6.0 million. The public offering price per unit wil
• $0.431 — n stock at an assumed purchase price of $0.431 per share and/or up to 2,083,333 additi

Filing Documents

• knwn_s1a.htm (S-1/A) — 1210KB
• knwn_ex11.htm (EX-1.1) — 337KB
• knwn_ex43.htm (EX-4.3) — 102KB
• knwn_ex51.htm (EX-5.1) — 15KB
• knwn_ex51img2.jpg (GRAPHIC) — 2KB
• knwn_ex51img4.jpg (GRAPHIC) — 2KB
• knwn_s1img1.jpg (GRAPHIC) — 7KB
• knwn_s1img19.jpg (GRAPHIC) — 7KB
• 0001654954-24-009267.txt ( ) — 1692KB

USE OF PROCEEDS

USE OF PROCEEDS 28 CAPITALIZATION 29

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 32

BUSINESS

BUSINESS 32 RESULTS OF OPERATIONS 39 DIRECTORS AND EXECUTIVE OFFICERS 47

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 54 DIRECTOR COMPENSATION 59

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 63 RELATED PARTY TRANSACTIONS OF DIRECTORS AND EXECUTIVE OFFICERS 64

DESCRIPTION OF SECURITIES

DESCRIPTION OF SECURITIES 71 MARKET FOR OUR COMMON STOCK, DIVIDENDS AND RELATED STOCKHOLDER INFORMATION 78 MATERIAL UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS FOR HOLDERS OF OUR COMMON STOCK 79 LEGAL MATTERS 85 EXPERTS 85 WHERE YOU CAN FIND MORE INFORMATION 85 DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES 85 INCORPORATION BY REFERENCE 86 iv Table of Contents ABOUT THIS PROSPECTUS This prospectus constitutes a part of a registration statement on Form S1 (or, together with all amendments and exhibits thereto, the "Registration Statement") filed by us with the Securities and Exchange Commission, or the SEC, under the Securities Act of 1933, as amended, or the Securities Act. As permitted by the rules and regulations of the SEC, this prospectus omits certain information contained in the Registration Statement, and reference is made to the Registration Statement and related exhibits for further information with respect to Know Labs, Inc. and the securities offered hereby. With regard to any statements contained herein concerning the provisions of any document filed as an exhibit to the Registration Statement or otherwise filed with the SEC, in each instance reference is made to the copy of such document so filed. Each such statement is qualified in its entirety by such reference. We incorporate by reference important information into this prospectus. You may obtain the information incorporated by reference without charge by following the instructions under " Where You Can Find More Information ." You should carefully read this prospectus as well as additional information described under " Incorporation of Certain Information by Reference ," before deciding to invest in our securities. You should rely only on the information contained in, or incorporated by reference into, this prospectus or in any related freewriting prospectus. We and the underwriters have not authorized anyone to provide any info

View Full Filing

View this S-1/A filing on SEC EDGAR